Food and Drug Administrations's Oversight of Clinical Investigators' Financial Information

摘要

The objective of the study is to describe the extent and nature of clinical investigators' disclosed financial interests reported to the Food and Drug Administration (FDA) for marketing applications approved in fiscal year (FY) 2007 and to assess FDA's oversight of clinical investigators' financial information.